IMU (ASX) Why IMU is NOT a MULTI Bagger is a BAGGIES company

Originally posted by valueadd: ↑

Hi 4 cents ..... a great post by you and right up there with your long held sentiments towards IMU - see my comments below

Quote :

Little to no meaningful efficacy across its range of products. Could change, but as yet not

Response : A very debatable statement ; and clearly you’ve not read many of the announcements & /or clarifications . Typically your knowledge of the progress IMU is scant - as usual
hing of remote interest to BP.

Poor management. You're either a Hopper lackey or you're out.

Response : I think you need to understand what IMU is primarily - Its a R & D company developing a number of potentially cutting edge remedies , that could well eclipse the currently accepted SoC treatments being administered .

The bio mechanics of these platforms , entails different pathways . Indications are that efficacy could be the same or better as SoC - but with minimal side effects .

The evolution of this knowledge comes with costs & Expenses

The Target markets and potential dwarf the cash burn

Fundamentally Its no different to an exploration company “ proving up” a massive in ground resource to use
3. Reactive, poorly-thought-out strategy changes. We're a "sell at Phase II" company until we fail to do so, now we run manufacturing facilities and deal in Phase 1 trials. Then again, if the overriding strategy is to get as many millions as possible to the Chair and management team before the company fails, then it may not be such a poorly thought out strategy.

Response Many would see this an opportunity seized ( no need to elaborate …as lots already been said about this ) , but perhaps you should understand Azer Cell ….. . I don't think you quite understand the doorways that this could open. Suggest you read the announcements and webinars on the subject .

4. Shareholders that accept and empower IMU's poor performance. How remuneration reports can be accepted after the company's performance, its value destroying capital raises, its questionable payment of an insane success fee and its failed-to-deliver-anything multi-million dollar BP liaison, beggars belief. Mind you, the online AGMs, with Paul pulling all the strings remotely, does make meaningful activism difficult.

Response - Lol …… yeah thats your opinion and of course you are entitled to it .

Once again I’m betting that there are lots of things going on in the background , discussions / exchanges of ideas etc …..

You only need to look at the progress made on so many fronts also to realize the work etc that goes into getting to where IMU currently is

IMU is and always has been a Long Play …..so while the impatient and ill informed think nothing is happening - perhaps they should read about timelines of other standard and now commonly accepted drugs and remedies

So many of the ills can be overlooked if you have what at least looks like a blockbuster drug and that's pretty much what happened after HER-Vaxx interim results were announced in 2020. Since then, HER-Vaxx proved a duster and nothing else has shown sufficient efficacy yet, so the pigeons have come home to roost.

Response - refer to the above comments

Once again , and as always you seem to lack any real clues as to where IMU are in their quest
to develop new drugs and remedies against Cancer .

But I guess that's not gunna change .....

So lets just see how things pan out ........

Are you a Woman's Weekly person ...or TV times ?

Have a great night

LOL

Expand

@valueadd, I cannot believe you put the time in to reply to that trash, what a waste of your talent

DYOR opinion only

No.	Vol.	Price($)
1	45087	5.2¢

No.

Vol.

Price($)

45087

5.2¢

Price($)	Vol.	No.
5.3¢	519803	5

Price($)

Vol.

No.

5.3¢

519803

No.	Vol.	Price($)
1	45087	0.052
11	671034	0.051
81	7658639	0.050
23	3483045	0.049
19	831259	0.048

No.

Vol.

Price($)

45087

0.052

671034

0.051

7658639

0.050

3483045

0.049

831259

0.048

Price($)	Vol.	No.
0.053	384611	4
0.054	2188679	7
0.055	670630	7
0.056	1929043	11
0.057	1626859	12

Price($)

Vol.

No.

0.053

384611

0.054

2188679

0.055

670630

0.056

1929043

0.057

1626859

(20min delay)
Last 5.2¢		Change -0.001(1.89%)		Mkt cap ! $382.1M

Open	High	Low	Value	Volume
5.4¢	5.4¢	5.1¢	$674.9K	12.90M

@valueadd, I cannot believe you put the time in to reply to that...

Commodity house Trafigura funds Develop Global's copper-zinc Woodlawn play with offtake deal in place

Westgold sets its sights on top five producer status through merger with Karora

Is oil undervalued?

Vmoto sales plummet -50% YoY as weak demand in Europe & China stifles EV scooter sales growth

Collaboration in a green (steel) future the focus for Magnum and Saudi partners

Venture to sniff out high-grade REE targets at Jupiter project, WA

GreenX picks up prospective copper project in Germany

Uranium prices on the NYMEX are stable, but ASX uranium stocks are sinking on Friday. The answer lies in Kazakhstan

Week 31 Wrap: JORC rules to get tougher; RBA rate hike chance 50/50; US Fed Sept cut still the quo

Cost blow-out for Rook I uranium project sees share plummet for NexGen

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

@valueadd, I cannot believe you put the time in to reply to that...

Top Stories

Commodity house Trafigura funds Develop Global's copper-zinc Woodlawn play with offtake deal in place

Westgold sets its sights on top five producer status through merger with Karora

Is oil undervalued?

Vmoto sales plummet -50% YoY as weak demand in Europe & China stifles EV scooter sales growth

Collaboration in a green (steel) future the focus for Magnum and Saudi partners

Venture to sniff out high-grade REE targets at Jupiter project, WA

GreenX picks up prospective copper project in Germany

Uranium prices on the NYMEX are stable, but ASX uranium stocks are sinking on Friday. The answer lies in Kazakhstan

Week 31 Wrap: JORC rules to get tougher; RBA rate hike chance 50/50; US Fed Sept cut still the quo

Cost blow-out for Rook I uranium project sees share plummet for NexGen

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News